Sarepta Therapeutics, Inc. Shares Outstanding 2009–2025
Sarepta Therapeutics, Inc. reported 105.0M of shares outstanding for fiscal 2025. That was 8.3% higher than fiscal 2024. Compared with fiscal 2020, the change was +32.2%. A rising share count can dilute per-share ownership; the filings should be checked for issuance and stock-compensation details.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2025 | 105.0M | +8.3% |
| FY 2024 | 96.9M | +3.4% |
| FY 2023 | 93.7M | +6.6% |
| FY 2022 | 88.0M | +0.9% |
| FY 2021 | 87.1M | +9.8% |
| FY 2020 | 79.4M | +5.6% |
| FY 2019 | 75.2M | +5.8% |
| FY 2018 | 71.1M | +9.7% |
| FY 2017 | 64.8M | +18.3% |
| FY 2016 | 54.8M | +20.0% |
| FY 2015 | 45.6M | +10.5% |
| FY 2014 | 41.3M | +9.4% |
| FY 2013 | 37.8M | +19.1% |
| FY 2012 | 31.7M | +40.1% |
| FY 2011 | 22.6M | +20.8% |
| FY 2010 | 18.7M | — |
| FY 2009 | 0.0M | — |
Source: Sarepta Therapeutics, Inc. SEC filings — balance sheet (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open SRPT 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Sarepta Therapeutics, Inc. reported 105.0M of shares outstanding for fiscal 2025. That was 8.3% higher than fiscal 2024. Compared with fiscal 2020, the change was +32.2%. A rising share count can dilute per-share ownership; the filings should be checked for issuance and stock-compensation details. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Sarepta Therapeutics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeSarepta Therapeutics, Inc. — frequently asked questions
What is Sarepta Therapeutics, Inc.'s shares outstanding?
Sarepta Therapeutics, Inc. (SRPT) reported shares outstanding of 105.0M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Sarepta Therapeutics, Inc.'s official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.
More SRPT financial history
Full SRPT fundamentals page → · Analyze shares outstanding with a free tool → · Research guide & leaders → · All 1,500+ companies →